Covidh Technologies Limited (BOM:534920)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	0.21	0.01	0.03	0.01	0.03
Short-Term Investments	-	-	-	-	-	11.23
Cash & Short-Term Investments	0.21	0.21	0.01	0.03	0.01	11.26
Cash Growth	1385.71%	1385.18%	-49.30%	179.53%	-99.91%	-9.16%
Accounts Receivable	-	3.13	-	-	-	29.14
Receivables	-	15.33	-	-	-	29.14
Other Current Assets	-	-	0.53	0.48	-	0.32
Total Current Assets	-	15.54	0.55	0.51	0.01	40.71
Property, Plant & Equipment	-	-	-	-	-	4.28
Other Long-Term Assets	-	0	-	-	-	-0
Total Assets	-	15.54	0.55	0.51	0.01	44.99
Accounts Payable	-	0.22	0.32	-	-	18.08
Current Unearned Revenue	-	-	0.25	0.25	-	-
Other Current Liabilities	-	0.24	0.29	0.17	0.06	7.44
Total Current Liabilities	-	0.46	0.86	0.42	0.06	25.52
Long-Term Debt	-	16.06	1.84	1.25	-	20.15
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.38
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	-	16.52	2.7	1.67	0.06	46.05
Common Stock	-	3.23	3.23	3	3.01	106
Retained Earnings	-	-4.21	-5.4	-4.17	-3.06	-107.06
Comprehensive Income & Other	-	-	0.01	0.01	-	-
Total Common Equity	-0.98	-0.98	-2.15	-1.16	-0.05	-1.06
Shareholders' Equity	-0.98	-0.98	-2.15	-1.16	-0.05	-1.06
Total Liabilities & Equity	-	15.54	0.55	0.51	0.01	44.99
Total Debt	16.06	16.06	1.84	1.25	-	20.15
Net Cash (Debt)	-15.85	-15.85	-1.83	-1.22	0.01	-8.9
Net Cash Per Share	-15.62	-49.48	-6.09	-4.08	-	-279.78
Filing Date Shares Outstanding	3.08	0.32	0.32	0.3	0.2	0.03
Total Common Shares Outstanding	3.08	0.32	0.32	0.3	0.2	0.03
Working Capital	-	15.08	-0.31	0.09	-0.05	15.2
Book Value Per Share	-3.06	-3.06	-6.65	-3.88	-0.23	-33.35
Tangible Book Value	-0.98	-0.98	-2.15	-1.16	-0.05	-1.06
Tangible Book Value Per Share	-3.06	-3.06	-6.65	-3.88	-0.23	-33.35
Machinery	-	-	-	-	-	16.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.